COMMUNIQUÉS West-GlobeNewswire

The Ensign Group Acquires Two Texas Assisted Living Facilities
05/02/2018
MISSION VIEJO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
The Ensign Group Schedules Year-End 2017 Earnings Call for Friday, February 9, 2018
05/02/2018
MISSION VIEJO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, assisted living, home health, [...]
REVA Announces Appointment of Stephen Oesterle, MD to Board of Directors
05/02/2018
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces the appointment of Stephen [...]
Rapid Micro Biosystems announces New Vice President of Operations
05/02/2018
LOWELL, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Mike Noyes as Vice President [...]
PolarityTE™ Provides Business Updates on Clinical Use of SkinTE™: Regeneration of Full-Thickness Skin
05/02/2018
SALT LAKE CITY, Feb. 05, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ: COOL ), today announced that initial results from the clinical applications of the commercially launched SkinTE are yielding outcomes that are [...]
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
05/02/2018
PLYMOUTH MEETING, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that the Company will participate in the following upcoming investment conferences: BIO CEO & [...]
OncBioMune Signs Letter of Intent to Initiate Phase 2 Trial of ProscaVax for Advanced Prostate Cancer with Urology Clinics of North Texas
05/02/2018
BATON ROUGE, La., Feb. 05, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Burcon Files Application for Controlled Drugs and Substances License to Pursue the Purified Cannabinoids Market
05/02/2018
VANCOUVER, British Columbia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”) a leader in natural product extraction, purification and isolation [...]
Sarepta Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
05/02/2018
CAMBRIDGE, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
BriaCell Presenting at Upcoming Cancer Conference
05/02/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director
05/02/2018
WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today [...]
EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery
05/02/2018
WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies [...]
Acer Therapeutics Expands Management Team with the Appointment of Three Executives and One New Key Hire
05/02/2018
Company appoints new VPs of Clinical Science, Manufacturing, and Finance and hires new Senior Director of Marketing New hires support Acer’s progression from development to potential commercialization of EDSIVO TM [...]
Progenics Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference
05/02/2018
NEW YORK, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced [...]
BeyondSpring Summarizes Key Messages from KOL Call regarding Lead Asset Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia
05/02/2018
NEW YORK , Feb. 05, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transforming immuno-oncology cancer therapies, today [...]
Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura
05/02/2018
HAYWARD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) is pleased to announce that the final patient has completed the last visit in the primary treatment phase of RESULT, a [...]
Canada House Wellness Group Now Included in the Emerging Marijuana ETF
05/02/2018
TORONTO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that it has been included in an Electronic Trading Fund “ETF” the Emerging [...]
ICYMI - Premier Biomedical CEO Interviewed on Fox Business “New To The Street” Program
05/02/2018
JACKSON CENTER, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) President and CEO, William A. Hartman was interviewed by host, Ken Evseroff, on the program “New To The Street”, which aired on [...]
Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.
05/02/2018
SHANGHAI, China and CUPERTINO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG ) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development of immunotherapies [...]

Pages